Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated polyradiculoneuritis that is progressive or relapsing over a period of at least 8 weeks. Although the exact pathogenesis is unclear, it is thought to be mediated by both cellular and humoral immune reactions dir...
Main Authors: | Min-Suk Yoon, Andrew Chan, Ralf Gold |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-05-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285611405564 |
Similar Items
-
Two years’ long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment
by: Gisa Ellrichmann, et al.
Published: (2017-02-01) -
Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy
by: Kalliopi Pitarokoili, et al.
Published: (2019-06-01) -
The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy
by: Kathleen M. Hagen, et al.
Published: (2021-03-01) -
Inhaled Solvent Abuse Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Salini Thulasirajah MB BCH, BAO, et al.
Published: (2020-06-01) -
Mitochondrial neurogastrointestinal encephalomyopathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy
by: Camila Pupe, et al.
Published: (2012-03-01)